Compagnie Lombard Odier SCmA’s bluebird bio BLUE Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-12	Closed	-$2K	–	608
2021 Q4	$2K	Buy	+12	New	+$2.83K	﹤0.01%	669
2017 Q2	–	Sell	-35	Closed	-$41K	–	712
2017 Q1	$41K	Sell	35 -54	-61%	-$55.1K	﹤0.01%	559
2016 Q4	$71K	Hold	89	–	–	﹤0.01%	566
2016 Q3	$78K	Sell	89 -23	-21%	-$16.7K	﹤0.01%	617
2016 Q2	$62K	Buy	112 +23	+26%	+$13K	﹤0.01%	634
2016 Q1	$49K	Hold	89	–	–	﹤0.01%	714
2015 Q4	$74K	Buy	+89	New	+$88.9K	﹤0.01%	640

Other funds holding BLUE

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Compagnie Lombard Odier SCmA's BLUE Position: Q1 2022 in Review

Compagnie Lombard Odier SCmA sold out of bluebird bio (BLUE) in Q1 2022, closing a stake of 12 shares — an estimated $2K sold.

Compagnie Lombard Odier SCmA first reported a position in BLUE in Q4 2015 and held it in 7 quarters. The position peaked at $78K in Q3 2016. 174 funds tracked by Wall St. Rank hold BLUE as of Q1 2022.

Compagnie Lombard Odier SCmA reported no remaining bluebird bio position as of Q1 2022 after selling out during the quarter.
Compagnie Lombard Odier SCmA sold 12 bluebird bio shares in Q1 2022, an estimated $2K.
Compagnie Lombard Odier SCmA first reported a position in bluebird bio in Q4 2015 and held it in 7 quarters.
Compagnie Lombard Odier SCmA's bluebird bio position peaked at $78K in Q3 2016.
174 funds tracked by Wall St. Rank held bluebird bio as of Q1 2022.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q1 2022, filed 27 Apr 2022.